BioWorld

Jan. 23, 2009

View Archived Issues

Study Finds Nondevelopmental Gene Critical for Neural Repair

Read More

Axikin Emerges as New Spinout to Pursue Respiratory Drugs

Following Actimis Pharmaceuticals Inc.'s structured buyout deal last June, the San Diego-based firm's investors decided to back a spinout venture with the company's remaining assets, forming Axikin Pharmaceuticals Inc. (BioWorld Today) Read More

Akesis Latest U.S. Biotech Firm to Face Bankruptcy

Read More

NewCo News: Asphelia Tackles 'Yuck Factor' of Helminth Egg-Based Drugs

Read More

Corrections & Clarifications

Read More

Lytix Adds $10M for Peptide Drugs to Treat Infectious Diseas

Read More

Other News To Note

Read More

U.S. Patent Disclosures

Read More

Clinic Roundup

Read More